Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -5.97 Million USD | 16.27% |
| 2023 | -7.14 Million USD | -57.58% |
| 2022 | -4.53 Million USD | 29.96% |
| 2021 | -6.46 Million USD | -176.57% |
| 2020 | -2.33 Million USD | 2.26% |
| 2019 | -2.39 Million USD | -63.26% |
| 2018 | -1.46 Million USD | -61.34% |
| 2017 | -908.56 Thousand USD | 39.42% |
| 2016 | -1.49 Million USD | -352.55% |
| 2015 | -331.41 Thousand USD | -53.67% |
| 2014 | -215.66 Thousand USD | -140.16% |
| 2013 | 536.95 Thousand USD | -2.09% |
| 2012 | 548.43 Thousand USD | 248.33% |
| 2011 | 157.44 Thousand USD | 147.5% |
| 2010 | -331.45 Thousand USD | -193.58% |
| 2009 | 354.18 Thousand USD | -79.29% |
| 2008 | 1.71 Million USD | 218.52% |
| 2007 | 536.87 Thousand USD | 133.15% |
| 2006 | 230.27 Thousand USD | 41.92% |
| 2005 | 162.25 Thousand USD | 172.7% |
| 2004 | -223.2 Thousand USD | 0.3% |
| 2003 | -223.86 Thousand USD | 46.79% |
| 2002 | -420.73 Thousand USD | 84.26% |
| 2001 | -2.67 Million USD | 31.32% |
| 2000 | -3.89 Million USD | -3790.85% |
| 1999 | -100 Thousand USD | -200.0% |
| 1998 | 100 Thousand USD | -75.0% |
| 1997 | 400 Thousand USD | 0.0% |
| 1996 | 400 Thousand USD | 300.0% |
| 1995 | 100 Thousand USD | 0.0% |
| 1994 | - USD | 100.0% |
| 1993 | -400 Thousand USD | 55.56% |
| 1992 | -900 Thousand USD | 25.0% |
| 1991 | -1.2 Million USD | -100.0% |
| 1990 | -600 Thousand USD | 33.33% |
| 1989 | -900 Thousand USD | -125.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.5 Million USD | -33.13% |
| 2024 Q1 | -1.13 Million USD | 36.84% |
| 2024 Q4 | -1.42 Million USD | 25.91% |
| 2024 Q3 | -1.91 Million USD | -27.27% |
| 2024 FY | -5.97 Million USD | 16.27% |
| 2023 FY | -7.14 Million USD | -57.58% |
| 2023 Q3 | -1.64 Million USD | -1.46% |
| 2023 Q1 | -2.07 Million USD | -17.79% |
| 2023 Q2 | -1.62 Million USD | 21.52% |
| 2023 Q4 | -1.79 Million USD | -8.63% |
| 2022 Q4 | -1.75 Million USD | -1588.64% |
| 2022 Q1 | -1.54 Million USD | -3.17% |
| 2022 Q2 | -1.12 Million USD | 27.05% |
| 2022 Q3 | -104.16 Thousand USD | 90.74% |
| 2022 FY | -4.53 Million USD | 29.96% |
| 2021 FY | -6.46 Million USD | -176.57% |
| 2021 Q1 | -1.64 Million USD | -238.99% |
| 2021 Q3 | -1.83 Million USD | -23.85% |
| 2021 Q2 | -1.48 Million USD | 9.96% |
| 2021 Q4 | -1.49 Million USD | 18.71% |
| 2020 Q1 | -506.29 Thousand USD | 35.53% |
| 2020 Q3 | -860.92 Thousand USD | -77.42% |
| 2020 Q2 | -485.26 Thousand USD | 4.15% |
| 2020 FY | -2.33 Million USD | 2.26% |
| 2020 Q4 | -486.57 Thousand USD | 43.48% |
| 2019 Q1 | -451.74 Thousand USD | 32.34% |
| 2019 Q2 | -477.24 Thousand USD | -5.65% |
| 2019 Q3 | -678.74 Thousand USD | -42.22% |
| 2019 Q4 | -785.33 Thousand USD | -15.7% |
| 2019 FY | -2.39 Million USD | -63.26% |
| 2018 Q2 | -268.66 Thousand USD | -29.75% |
| 2018 Q1 | -207.05 Thousand USD | 40.13% |
| 2018 Q3 | -322.49 Thousand USD | -20.04% |
| 2018 FY | -1.46 Million USD | -61.34% |
| 2018 Q4 | -667.61 Thousand USD | -107.02% |
| 2017 Q4 | -345.82 Thousand USD | -13.7% |
| 2017 Q1 | -55.41 Thousand USD | 95.48% |
| 2017 FY | -908.56 Thousand USD | 39.42% |
| 2017 Q2 | -202.88 Thousand USD | -266.11% |
| 2017 Q3 | -304.14 Thousand USD | -49.91% |
| 2016 Q2 | -66.76 Thousand USD | 7.7% |
| 2016 Q4 | -1.22 Million USD | -807.9% |
| 2016 Q1 | -72.33 Thousand USD | -129.76% |
| 2016 FY | -1.49 Million USD | -352.55% |
| 2016 Q3 | -135 Thousand USD | -102.2% |
| 2015 FY | -331.41 Thousand USD | -53.67% |
| 2015 Q3 | -117.19 Thousand USD | 50.77% |
| 2015 Q4 | 243.07 Thousand USD | 307.41% |
| 2015 Q1 | -219.26 Thousand USD | -229.84% |
| 2015 Q2 | -238.02 Thousand USD | -8.56% |
| 2014 Q1 | -167.71 Thousand USD | -481.0% |
| 2014 FY | -215.66 Thousand USD | -140.16% |
| 2014 Q3 | 26.54 Thousand USD | 110.91% |
| 2014 Q2 | -243.35 Thousand USD | -45.1% |
| 2014 Q4 | 168.87 Thousand USD | 536.2% |
| 2013 FY | 536.95 Thousand USD | -2.09% |
| 2013 Q4 | 44.02 Thousand USD | 223.6% |
| 2013 Q3 | -35.61 Thousand USD | -115.03% |
| 2013 Q2 | 236.91 Thousand USD | -18.76% |
| 2013 Q1 | 291.64 Thousand USD | 439.02% |
| 2012 Q2 | 195.09 Thousand USD | 65.62% |
| 2012 Q3 | 181.44 Thousand USD | -7.0% |
| 2012 Q4 | 54.1 Thousand USD | -70.18% |
| 2012 Q1 | 117.79 Thousand USD | 22.58% |
| 2012 FY | 548.43 Thousand USD | 248.33% |
| 2011 FY | 157.44 Thousand USD | 147.5% |
| 2011 Q3 | 73.4 Thousand USD | 53478.83% |
| 2011 Q1 | -12.18 Thousand USD | 92.72% |
| 2011 Q2 | 137.00 USD | 101.12% |
| 2011 Q4 | 96.09 Thousand USD | 30.91% |
| 2010 Q4 | -167.3 Thousand USD | -225.21% |
| 2010 Q2 | -305.7 Thousand USD | -3953.11% |
| 2010 FY | -331.45 Thousand USD | -193.58% |
| 2010 Q1 | 7934.00 USD | -79.98% |
| 2010 Q3 | 133.62 Thousand USD | 143.71% |
| 2009 Q3 | 276.74 Thousand USD | 368.64% |
| 2009 Q4 | 39.64 Thousand USD | -85.68% |
| 2009 Q1 | 140.81 Thousand USD | -79.81% |
| 2009 Q2 | -103.01 Thousand USD | -173.16% |
| 2009 FY | 354.18 Thousand USD | -79.29% |
| 2008 Q4 | 697.45 Thousand USD | 463.17% |
| 2008 FY | 1.71 Million USD | 218.52% |
| 2008 Q2 | 3358.00 USD | -99.62% |
| 2008 Q1 | 885.38 Thousand USD | 194.91% |
| 2008 Q3 | 123.84 Thousand USD | 3588.03% |
| 2007 Q3 | 121.37 Thousand USD | 14.02% |
| 2007 Q1 | 64.57 Thousand USD | -52.33% |
| 2007 FY | 536.87 Thousand USD | 133.15% |
| 2007 Q4 | 300.22 Thousand USD | 147.37% |
| 2007 Q2 | 106.44 Thousand USD | 64.85% |
| 2006 Q3 | 29.61 Thousand USD | 1542.54% |
| 2006 Q2 | 1803.00 USD | -97.16% |
| 2006 Q1 | 63.39 Thousand USD | -69.68% |
| 2006 FY | 230.27 Thousand USD | 41.92% |
| 2006 Q4 | 135.46 Thousand USD | 357.42% |
| 2005 Q3 | 72.13 Thousand USD | 204.8% |
| 2005 FY | 162.25 Thousand USD | 172.7% |
| 2005 Q2 | -68.83 Thousand USD | -37.27% |
| 2005 Q1 | -50.14 Thousand USD | -211.17% |
| 2005 Q4 | 209.1 Thousand USD | 189.87% |
| 2004 Q3 | 63.17 Thousand USD | 155.61% |
| 2004 Q1 | -217.88 Thousand USD | -280.63% |
| 2004 FY | -223.2 Thousand USD | 0.3% |
| 2004 Q4 | 45.1 Thousand USD | -28.6% |
| 2004 Q2 | -113.59 Thousand USD | 47.86% |
| 2003 Q1 | -135.46 Thousand USD | -433.4% |
| 2003 FY | -223.86 Thousand USD | 46.79% |
| 2003 Q4 | 120.62 Thousand USD | 561.56% |
| 2003 Q3 | -26.13 Thousand USD | 84.49% |
| 2003 Q2 | -168.46 Thousand USD | -24.36% |
| 2002 Q3 | 17.82 Thousand USD | 112.55% |
| 2002 Q2 | -142 Thousand USD | 53.32% |
| 2002 Q1 | -304.19 Thousand USD | 54.38% |
| 2002 FY | -420.73 Thousand USD | 84.26% |
| 2002 Q4 | 40.63 Thousand USD | 127.92% |
| 2001 FY | -2.67 Million USD | 31.32% |
| 2001 Q1 | -927.08 Thousand USD | 30.49% |
| 2001 Q2 | -592.02 Thousand USD | 36.14% |
| 2001 Q3 | -513.84 Thousand USD | 13.21% |
| 2001 Q4 | -666.84 Thousand USD | -29.78% |
| 2000 Q4 | -1.33 Million USD | -49.47% |
| 2000 Q2 | -700 Thousand USD | 30.0% |
| 2000 Q1 | -1 Million USD | -1100.0% |
| 2000 Q3 | -892.38 Thousand USD | -27.48% |
| 2000 FY | -3.89 Million USD | -3790.85% |
| 1999 FY | -100 Thousand USD | -200.0% |
| 1999 Q1 | - USD | 100.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | -200 Thousand USD | 0.0% |
| 1999 Q4 | 100 Thousand USD | 150.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q2 | - USD | -100.0% |
| 1998 Q4 | -100 Thousand USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | 100 Thousand USD | -75.0% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 FY | 400 Thousand USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | -50.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 FY | 400 Thousand USD | 300.0% |
| 1996 Q4 | 200 Thousand USD | 100.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 FY | 100 Thousand USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 100.0% |
| 1994 Q2 | - USD | 100.0% |
| 1994 Q3 | -100 Thousand USD | 0.0% |
| 1994 Q1 | -100 Thousand USD | 0.0% |
| 1994 FY | - USD | 100.0% |
| 1993 Q1 | 100 Thousand USD | 120.0% |
| 1993 FY | -400 Thousand USD | 55.56% |
| 1993 Q4 | -100 Thousand USD | 0.0% |
| 1993 Q3 | -100 Thousand USD | 0.0% |
| 1993 Q2 | -100 Thousand USD | -200.0% |
| 1992 Q3 | -300 Thousand USD | -200.0% |
| 1992 Q4 | -500 Thousand USD | -66.67% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q2 | -100 Thousand USD | 0.0% |
| 1992 FY | -900 Thousand USD | 25.0% |
| 1991 FY | -1.2 Million USD | -100.0% |
| 1991 Q1 | -100 Thousand USD | 0.0% |
| 1991 Q2 | - USD | 100.0% |
| 1991 Q3 | -200 Thousand USD | 0.0% |
| 1991 Q4 | -800 Thousand USD | -300.0% |
| 1990 Q1 | -100 Thousand USD | 75.0% |
| 1990 Q3 | -300 Thousand USD | 0.0% |
| 1990 Q2 | - USD | 100.0% |
| 1990 Q4 | - USD | 100.0% |
| 1990 FY | -600 Thousand USD | 33.33% |
| 1989 Q3 | -100 Thousand USD | 0.0% |
| 1989 Q4 | -400 Thousand USD | -300.0% |
| 1989 FY | -900 Thousand USD | -125.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 90.298% |
| BrainsWay Ltd. | -4.19 Million USD | -42.435% |
| Cerus Corporation | -37.48 Million USD | 84.054% |
| Envoy Medical, Inc. | -29.9 Million USD | 80.012% |
| electroCore, Inc. | -18.83 Million USD | 68.26% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 32.452% |
| IceCure Medical Ltd | -14.65 Million USD | 59.2% |
| Inogen, Inc. | -102.44 Million USD | 94.165% |
| OrthoPediatrics Corp. | -20.97 Million USD | 71.498% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 88.649% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 56.509% |
| MaxCyte, Inc. | -37.92 Million USD | 84.236% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 49.593% |
| Nexalin Technology, Inc. | -4.64 Million USD | -28.595% |
| Orthofix Medical Inc. | -151.39 Million USD | 96.051% |
| PAVmed Inc | -64.17 Million USD | 90.685% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 88.606% |
| RxSight, Inc. | -48.6 Million USD | 87.702% |
| Sight Sciences, Inc. | -55.54 Million USD | 89.238% |
| SI-BONE, Inc. | -43.33 Million USD | 86.205% |
| TELA Bio, Inc. | -46.66 Million USD | 87.189% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 87.93% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 55.989% |
| Acutus Medical, Inc. | -81.66 Million USD | 92.68% |
| Talis Biomedical Corporation | -62 Million USD | 90.359% |
| Spectral AI, Inc. | -20.85 Million USD | 71.334% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 90.164% |
| CVRx, Inc. | -41.19 Million USD | 85.49% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1033.777% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 45.433% |
| Bioventus Inc. | -156.23 Million USD | 96.174% |
| Venus Concept Inc. | -37.25 Million USD | 83.952% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 89.874% |
| LivaNova PLC | 17.54 Million USD | 134.07% |
| 908 Devices Inc. | -36.39 Million USD | 83.576% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 96.797% |
| Nemaura Medical Inc. | -14.14 Million USD | 57.734% |
| NeuroPace, Inc. | -32.95 Million USD | 81.861% |
| LENSAR, Inc. | -14.38 Million USD | 58.437% |
| Apyx Medical Corporation | -18.71 Million USD | 68.054% |
| Cutera, Inc. | -162.83 Million USD | 96.329% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 44.801% |
| BioSig Technologies, Inc. | -29.04 Million USD | 79.415% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 92.769% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 72.937% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 108.825% |
| Axonics, Inc. | -6.08 Million USD | 1.807% |
| Outset Medical, Inc. | -172.79 Million USD | 96.54% |
| IRIDEX Corporation | -9.57 Million USD | 37.534% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 94.355% |
| IRadimed Corporation | 17.19 Million USD | 134.77% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 27.487% |
| INVO Bioscience, Inc. | -8.03 Million USD | 25.597% |
| Telesis Bio, Inc. | -47.72 Million USD | 87.474% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 158.362% |
| Varex Imaging Corporation | -47.7 Million USD | 87.468% |
| Quipt Home Medical Corp. | -2.78 Million USD | -114.727% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 47.032% |
| Pulmonx Corporation | -60.84 Million USD | 90.175% |
| Dynatronics Corporation | -2.69 Million USD | -121.595% |
| Modular Medical, Inc. | -17.47 Million USD | 65.781% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 47.502% |
| Semler Scientific, Inc. | 20.58 Million USD | 129.043% |
| InMode Ltd. | 197.91 Million USD | 103.02% |
| Bruker Corporation | 427.2 Million USD | 101.399% |
| Cytosorbents Corporation | -28.5 Million USD | 79.03% |
| DexCom, Inc. | 541.5 Million USD | 101.104% |
| Align Technology, Inc. | 445.05 Million USD | 101.343% |
| Viveve Medical, Inc. | -22.02 Million USD | 72.861% |
| ZimVie Inc. | -393.28 Million USD | 98.48% |
| Movano Inc. | -29.28 Million USD | 79.585% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 50.79% |
| Nexalin Technology, Inc. | -4.64 Million USD | -28.595% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1033.777% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 97.315% |
| Profound Medical Corp. | -28.56 Million USD | 79.075% |
| Insulet Corporation | 206.3 Million USD | 102.898% |
| enVVeno Medical Corporation | -23.51 Million USD | 74.579% |
| Surmodics, Inc. | -11.54 Million USD | 48.207% |
| iCAD, Inc. | -4.84 Million USD | -23.334% |
| Nuwellis, Inc. | -20.2 Million USD | 70.419% |
| Biotricity, Inc. | -14.09 Million USD | 57.586% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 95.156% |
| Aethlon Medical, Inc. | -12.2 Million USD | 51.033% |
| InspireMD, Inc. | -19.91 Million USD | 69.984% |
| PAVmed Inc. | -64.17 Million USD | 90.685% |
| BIOLASE, Inc. | -20.63 Million USD | 71.026% |
| Beyond Air, Inc. | -60.24 Million USD | 90.077% |
| FONAR Corporation | 10.56 Million USD | 156.57% |
| AxoGen, Inc. | -21.71 Million USD | 72.472% |
| Vivani Medical, Inc. | -25.65 Million USD | 76.696% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 120.964% |
| Inari Medical, Inc. | -1.63 Million USD | -265.403% |
| UFP Technologies, Inc. | 44.92 Million USD | 113.307% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -16.477% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 9.496% |
| Tenon Medical, Inc. | -15.58 Million USD | 61.633% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 61.247% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 83.081% |
| AdaptHealth Corp. | -678.89 Million USD | 99.119% |
| Sintx Technologies, Inc. | -8.25 Million USD | 27.618% |
| NanoVibronix, Inc. | -3.71 Million USD | -61.089% |
| Quanterix Corporation | -32.33 Million USD | 81.512% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 47.032% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1332.577% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.051% |
| TransMedics Group, Inc. | -25.02 Million USD | 76.115% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 72.991% |
| NeuroMetrix, Inc. | -6.52 Million USD | 8.446% |
| Hyperfine, Inc. | -44.23 Million USD | 86.487% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 92.385% |
| Bone Biologics Corporation | -8.94 Million USD | 33.197% |
| AVITA Medical, Inc. | -39.16 Million USD | 84.738% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 39.943% |
| Silk Road Medical, Inc | -55.74 Million USD | 89.276% |